SULT2B1 and neoplasm: Functional analysis proves that SULT2B1 overexpression in vitro reduces tumor cell proliferation and retard tumor growth in vivo, while SULT2B1b knockdown promotes ESCC progression (Yue et al., 2017; Li et al., 2021).